Alphatec Holdings (ATEC) Liabilities and Shareholders Equity (2010 - 2026)
Alphatec Holdings' (ATEC) quarterly Liabilities and Shareholders Equity came in at $791.0 million in Q2 2026, little changed year-over-year from $790.3 million in Q2 2025, and down 1.06% quarter-over-quarter from $799.5 million in Q1 2026.
Analysis
Alphatec Holdings (ATEC) Liabilities and Shareholders Equity (2010 - 2026) Analysis & Trends
Alphatec Holdings has disclosed Liabilities and Shareholders Equity across 17 years of filings, most recently posting $791.0 million for Q2 2026.
- In Q2 2026, Liabilities and Shareholders Equity changed 0.09% year-over-year to $791.0 million; the TTM figure through Jun 2026 stood at $3.2 billion (up 2.31% YoY), while the FY2025 annual figure was $791.2 million, up 2.0% from the prior year.
- Liabilities and Shareholders Equity came in at $791.0 million for Q2 2026 at Alphatec Holdings, down from $799.5 million in the prior quarter.
- In the past five years, Liabilities and Shareholders Equity ranged from a high of $805.2 million in Q4 2023 to a low of $511.9 million in Q2 2022.
- Average Liabilities and Shareholders Equity over 5 years is $698.9 million, with a median of $771.6 million recorded in 2024.
- Year-over-year, Liabilities and Shareholders Equity fell 13.68% in 2022 and surged 54.56% in 2023.
- Over 5 years, Liabilities and Shareholders Equity stood at $521.0 million in 2022, then surged by 54.56% to $805.2 million in 2023, then declined by 3.66% to $775.7 million in 2024, then advanced by 2.0% to $791.2 million in 2025, then dropped by 0.02% to $791.0 million in 2026.
- Per Business Quant data, the three most recent Liabilities and Shareholders Equity figures were $791.0 million in Q2 2026, $799.5 million in Q1 2026, and $791.2 million in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 179.79 Bn | 174.18 Bn | 7.27 Bn | 109.22 Bn |
| 2 | Intuitive Surgical | 127.69 Bn | 122.47 Bn | 1.96 Bn | 20.88 Bn |
| 3 | Medtronic | 117.23 Bn | 108.41 Bn | 6.34 Bn | 93.31 Bn |
| 4 | Stryker | 103.55 Bn | 100.07 Bn | 4.50 Bn | 47.93 Bn |
| 5 | Boston Scientific | 63.24 Bn | 62.70 Bn | 3.85 Bn | 45.22 Bn |
| 6 | Edwards Lifesciences | 49.97 Bn | 45.72 Bn | 1.35 Bn | 13.87 Bn |
| 7 | Alcon | 32.83 Bn | 31.37 Bn | 1.68 Bn | 31.10 Bn |
| 8 | Dexcom | 32.30 Bn | 30.35 Bn | 830.00 Mn | 6.46 Bn |
| 9 | Steris | 20.73 Bn | 20.25 Bn | 684.20 Mn | 10.74 Bn |
| 10 | Alphatec Holdings | 1.38 Bn | 1.26 Bn | 154.10 Mn | 791.03 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 791.03 Mn |
| Mar 31, 2026 | 799.48 Mn |
| Dec 31, 2025 | 791.21 Mn |
| Sep 30, 2025 | 787.25 Mn |
| Jun 30, 2025 | 790.29 Mn |
| Mar 31, 2025 | 785.47 Mn |
| Dec 31, 2024 | 775.71 Mn |
| Sep 30, 2024 | 745.90 Mn |
| Jun 30, 2024 | 768.59 Mn |
| Mar 31, 2024 | 774.58 Mn |
| Dec 31, 2023 | 805.21 Mn |
| Sep 30, 2023 | 670.22 Mn |
| Jun 30, 2023 | 628.23 Mn |
| Mar 31, 2023 | 569.69 Mn |
| Dec 31, 2022 | 520.97 Mn |
| Sep 30, 2022 | 516.28 Mn |
| Jun 30, 2022 | 511.94 Mn |
| Mar 31, 2022 | 548.69 Mn |
| Dec 31, 2021 | 572.05 Mn |
| Sep 30, 2021 | 598.11 Mn |